芬兰Ani Labsystems Ltd  

Ani Labsystems Ltd. Oy is an established Finnish diagnostics company dedicated to the production and sales of immunoassays. The core business is EIAs and FEIAs for infectious diseases, neonatal screening and other disorders.

Our infectious disease kits with proven high quality come with easy-to-use components and breakable strips. Kits with calibrators give semi quantitative results. The products have a long shelf life and they are suitable for both manual and fully automated systems.

In our neonatal product range we can offer well established, easy-to-use, quantitative tests with long shelf-life. The tests are calibrated against international references, when applicable. The tests are suitable for all open screening systems.

Good customer service guarantees fast and flexible delivery through a wide distributor network all over the world.

Within 25 years of experience, throughout different ownerships (formerly Labsystems), Ani Labsystems has been a key pioneer in the development of the first microplate assays, screening of metabolic disorders for neonates and avidity methods.

We strongly invest in research and development, in our highly qualified personnel and state of the art production systems. A highly rigorous quality system, complying with ISO 13485:2003 and IVD directive 98/79/EC, ensures sustainable quality of our products.

These assets combined with efficient customer support, long term customer satisfaction and a solid reputation ensure future success for Ani Labsystems and our partners.

Ani Labsystems has extensive experience in developing EIA assays in microplate format:

One of the world's first EIA tests (Toxoplasma gondii IgG EIA) in microplate format (1982)
One of the world's first HIV tests based on peptide technology (HIV-1+2 env. Peptide EIA) (1988)
The world's first fluorometric PKU test in microplate format (1990)
The world's first and only Toxoplasma gondii IgM test for neonatal screening (1995)
One of the world's first species-specific Chlamydia trachomatis EIAs (1997)
One of the world's first species-specific Chlamydia pneumoniae EIAs (1999)
One of the first EIA kits in the EU with CE-mark (Mycoplasma pneumoniae EIAs)(2000)
The world's first and only EIA for detection of Celiac disease by using the patient's own antigen-antibody complex (2005)
Unique IgD EIA kit for quantitative determination of IgD (2006